PolyPeptide Group AG (SWX:PPGN)
37.75
-0.55 (-1.44%)
Jun 3, 2026, 3:01 PM CET
PolyPeptide Group AG Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, PolyPeptide Group AG stock has a consensus rating of "Buy" and an average price target of CHF 35.63. The average 1-year stock price forecast is 5.62% lower than the current stock price, while the lowest is CHF 25.23 (-33.17%) and the highest is CHF 43.47 (+15.15%).
Price Target: CHF 35.63 (-5.62%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for PolyPeptide Group AG stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 3 | 3 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Buy Maintains CHF 40.00 | Buy | Maintains | CHF 40.00 | +5.96% | May 7, 2026 |
| RBC Capital | RBC Capital | Buy Maintains CHF 44.00 | Buy | Maintains | CHF 44.00 | +16.56% | Apr 13, 2026 |
Unknown Analyst Berenberg Bank No rating | Berenberg Bank | Buy Maintains CHF 35.00 | Buy | Maintains | CHF 35.00 | -7.28% | Mar 31, 2026 |
| Barclays | Barclays | Buy Maintains CHF 35.00 → CHF 33.00 | Buy | Maintains | CHF 35.00 → CHF 33.00 | -12.58% | Jan 6, 2026 |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. The data is sourced from Wall Street analysts. Data sources.